Escitalopram Oxalate Price Trend and Forecast 2026-2027

Escitalopram Oxalate prices in the United States rose 2.1% in Q2 2026 to USD 34,200.00/MT from USD 33,500.00/MT in Q1, extending a sharp reversal that took hold as the Middle East conflict's energy and feedstock cost impact combined with recovering pharmaceutical manufacturing demand to overturn a genuinely deflationary 2025. Globally, the average rose from USD 28,890.00/MT in Q1 to USD 29,542.00/MT in Q2, a 2.3% gain, following a jump of more than 18 percent in Q1 alone. For H2 2026, a global average of USD 27,500.00-32,500.00/MT is expected, with elevated fluorinated aromatic feedstock costs likely to keep this market firm even as the pace of further gains moderates.

Escitalopram Oxalate is the oxalate salt of escitalopram, the S-enantiomer of citalopram and one of the world's most prescribed selective serotonin reuptake inhibitors, used primarily to treat major depressive disorder and generalized anxiety disorder. Its synthesis involves fluorinated aromatic building blocks, chiral resolution or asymmetric synthesis to isolate the pharmacologically active S-enantiomer, and oxalic acid salt formation to produce the stable, water-soluble form used in tablets and oral solutions. China dominates global active pharmaceutical ingredient manufacture through GMP-certified facilities, with India as a significant secondary producer and formulator for the generic market, and procurement governed by volume tendering with Chinese and Indian producers competing on price to set the cost benchmark. Fluorinated aromatic precursor and oxalic acid feedstock costs, Chinese manufacturing overcapacity conditions, and generic pharmaceutical demand are what drive prices in this market.

Escitalopram Oxalate Price Forecast for 2026

The outlook for Escitalopram Oxalate through H2 2026 stays firm, tracking elevated fluorinated aromatic precursor costs, which are linked to benzene and naphtha economics, alongside broader energy market disruption affecting Chinese electricity and natural gas costs for synthesis and distillation operations. Recovering pharmaceutical manufacturing demand should continue supporting consumption even as Chinese chemical sector overcapacity conditions, the primary structural headwind that drove 2025's deflationary pressure, remain a factor capable of limiting the pace of further gains.

The main upside risk is a further escalation of Middle East energy market disruption affecting fluorinated aromatic feedstock costs, which could push prices higher than currently forecast. The main downside risk is a resumption of the Chinese chemical sector overcapacity conditions that drove 2025's deflationary pressure, which could cap or reverse the current recovery once the acute feedstock shock fades.

For the Quarter Ending June 2026

Escitalopram Oxalate Prices Q2 2026:

• United States: USD 34,200.00/MT
• Germany: USD 30,500.00/MT
• India: USD 27,400.00/MT
• China: USD 25,100.00/MT

Escitalopram Oxalate Prices in the United States

US Escitalopram Oxalate prices averaged USD 34,200.00/MT in Q2 2026, the highest of any region tracked here, up 2.1% from USD 33,500.00/MT in Q1, as strong consumer demand and rising production costs continued supporting this market.

Why did the price of Escitalopram Oxalate change in Q2 2026 in the United States?

Strong consumer spending and general inflation continued contributing to higher operational and raw material costs, while rising production costs tied to fluorinated aromatic feedstock economics kept this market at the top of the range tracked in this report.

Escitalopram Oxalate Prices in Germany

German prices averaged USD 30,500.00/MT in Q2 2026, up 2.3% from USD 29,800.00/MT in Q1, as recovering industrial production continued supporting this market's reversal from 2025's deflationary conditions.

Why did the price of Escitalopram Oxalate change in Q2 2026 in Germany?

Recovering industrial production and demand, following the stagnating economic activity that had characterized much of 2025, continued supporting this market's reversal even as the pace of further gains moderated.

Escitalopram Oxalate Prices in India

Indian prices averaged USD 27,400.00/MT in Q2 2026, up 2.2% from USD 26,800.00/MT in Q1, as growing generic formulation demand kept this market on a firm upward path.

Why did the price of Escitalopram Oxalate change in Q2 2026 in India?

Growing generic pharmaceutical demand, tied to expanding mental health awareness and treatment access, kept Indian formulators active even as feedstock costs moved higher through the quarter.

Escitalopram Oxalate Prices in China

Chinese prices averaged USD 25,100.00/MT in Q2 2026, the lowest of the four regions, up 2.4% from USD 24,500.00/MT in Q1, as elevated energy costs continued supporting this market even amid persistent overcapacity conditions.

Why did the price of Escitalopram Oxalate change in Q2 2026 in China?

Chinese electricity and natural gas costs for synthesis and distillation operations stayed elevated, tied to the broader Middle East-linked energy market disruption, even as chemical sector overcapacity conditions kept this market the most affordable tracked in this report.

For the Quarter Ending March 2026

Escitalopram Oxalate Prices Q1 2026:

• United States: USD 33,500.00/MT
• Germany: USD 29,800.00/MT
• India: USD 26,800.00/MT
• China: USD 24,500.00/MT

Escitalopram Oxalate Prices in the United States

US prices surged 15.5% in Q1 2026 to USD 33,500.00/MT from USD 29,000.00/MT in Q4 2025, as the conflict's energy and feedstock cost impact combined with recovering pharmaceutical manufacturing demand.

Why did the price of Escitalopram Oxalate change in Q1 2026 in the United States?

Escitalopram Oxalate prices firmed broadly through Q1 2026 as the conflict's energy and feedstock cost impact combined with recovering pharmaceutical manufacturing demand to reverse the deflationary pressure that had characterized Asian and European markets through much of 2025.

Escitalopram Oxalate Prices in Germany

German prices surged 18.3% in Q1 2026 to USD 29,800.00/MT from USD 25,200.00/MT in Q4 2025, reversing the deflationary pressure that had characterized this market through most of 2025.

Why did the price of Escitalopram Oxalate change in Q1 2026 in Germany?

Fluorinated aromatic precursors, derived from fluorobenzene chemistry and linked to benzene and naphtha economics, became the most significant organic feedstock cost variable as the broader energy market disruption pushed those costs sharply higher, reversing the declining industrial production trend that had weighed on this market through 2025.

Escitalopram Oxalate Prices in India

Indian prices surged 20.7% in Q1 2026 to USD 26,800.00/MT from USD 22,200.00/MT in Q4 2025, tracking the broader global feedstock cost reversal.

Why did the price of Escitalopram Oxalate change in Q1 2026 in India?

China's dominant producer role means that Chinese electricity and natural gas costs for synthesis and distillation operations are the primary price determinants for the global API market, and as those costs surged following the conflict's outbreak, Indian formulators, who compete on price with Chinese producers to set the cost benchmark, saw import and production costs rise sharply in tandem.

Escitalopram Oxalate Prices in China

Chinese prices surged 20.7% in Q1 2026 to USD 24,500.00/MT from USD 20,300.00/MT in Q4 2025, as elevated energy costs reversed the deflationary trend that had characterized the market through most of 2025.

Why did the price of Escitalopram Oxalate change in Q1 2026 in China?

Chinese chemical sector overcapacity conditions, which had driven a genuine deflationary trend through most of 2025 with producer prices declining year-on-year, gave way to a sharp reversal as natural gas prices rose and electricity costs for synthesis and distillation operations increased following the broader energy market disruption.

Quarterly Escitalopram Oxalate Price Trends

Global Escitalopram Oxalate prices declined through most of 2025 as Chinese chemical sector overcapacity conditions drove a genuine deflationary trend across Asian and European markets, before a sharp reversal took hold in Q1 2026 as the Middle East conflict's energy and feedstock cost impact combined with recovering pharmaceutical manufacturing demand to push prices to their highest levels of the period.

What was Escitalopram Oxalate Price in 2025?

Escitalopram Oxalate told a genuinely mixed story across 2025. The United States posted a modest annual gain tracking rising production costs and strong consumer demand, while Germany, India, and China all saw net annual declines, reflecting the deflationary pressure tied to Chinese chemical sector overcapacity that characterized much of the year before a sharp reversal took hold in early 2026.

Escitalopram Oxalate Prices in the United States in 2025

US prices firmed from about USD 28,000.00/MT in Q1 2025 to USD 29,000.00/MT by Q4, a gain of roughly 3.6%, the only region among the four to post a positive annual figure, tracking rising production costs and strong consumer demand throughout the year.

Escitalopram Oxalate Prices in Germany in 2025

German prices declined from about USD 26,000.00/MT in Q1 2025 to USD 25,200.00/MT by Q4, down roughly 3.1%, tracking the broader deflationary pressure tied to Chinese chemical sector overcapacity.

Escitalopram Oxalate Prices in India in 2025

Indian prices declined from about USD 23,000.00/MT in Q1 2025 to USD 22,200.00/MT by Q4, down roughly 3.5%, the steepest annual decline of the four regions, before the sharp Q1 2026 reversal that followed.

Escitalopram Oxalate Prices in China in 2025

Chinese prices declined from about USD 21,000.00/MT in Q1 2025 to USD 20,300.00/MT by Q4, down roughly 3.3%, reflecting genuine chemical sector overcapacity conditions that persisted through most of the year before energy cost pressure reversed the trend.

How We Can Help

Expert Market Research: Your Source for Real-Time Escitalopram Oxalate Price Intelligence

Expert Market Research tracks Escitalopram Oxalate prices continuously across every major producing and consuming region, combining fluorinated aromatic precursor and oxalic acid feedstock cost data, Chinese manufacturing overcapacity trends, and generic pharmaceutical demand signals into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the deflationary-to-reversal trends covered in this report, and build a defensible view of where this widely prescribed antidepressant API is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.